Detail
LncRNA Name | LINC00210 |
Synonyms | LINC00210, RP11-72L13.1 |
Region | GRCh38_1:217892900-217920804 Sequence |
Ensembl | ENSG00000231814 |
RefSeq | NR_048550 |
Circulating | ✘ |
Drug-resisitant | ✔ |
Prognostic | ✘ |
MiRNA | ✘ |
Variant | ✘ |
TF | ✘ |
Methylation | ✘ |
Cancer Name | liver cancer |
ICD-0-3 | C22.0 |
Methods | Microarray, qPCR, RIP, in vitro knockdown |
Sample | cell lines (Hep3B (ATCC HB-8064),PLC (ATCC CRL-8024),293 T (ATCC CRL-3216)), liver cancer tissues |
Expression Pattern | up-regulated |
Function Description | Linc00210 promoted self-renewal and tumor initiating capacity of liver TICs through Wnt/B-catenin signaling. Linc00210 interacted with CTNNBIP1 and blocked its inhibitory role in Wnt/B-catenin activation. Linc00210 silencing cells showed enhanced interaction of B-catenin and CTNNBIP1, and impaired interaction of B-catenin and TCF/LEF components.Linc00210 interacts with CTNNBIP1 and blocks the combination between CTNNBIP1 and B-catenin, driving the activation of Wnt/B-catenin signaling. Linc00210-CTNNBIP1-Wnt/B-catenin axis can be targeted for liver TIC elimination. |
Pubmed ID | 29540185 |
Year | 2018 |
Title | Linc00210 drives Wnt/B-catenin signaling activation and liver tumor progression through CTNNBIP1-dependent manner. |
External Links |
Links for LINC00210 | GenBank HGNC lncrnadb Noncode |
Links for liver cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.